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Abstract
Standard treatment of patients with coexisting cardiac and non-cardiac diseases includes two separate operations.
We report a case of 55-year-old man with combined valvular heart disease and renal carcinoma infiltrating inferior
caval vein, who underwent one-stage cardio-urologic procedure. In the first step, mitral and tricuspid valvuloplasty
were performed by cardiac surgeons. Then, urologists performed radical nephrectomy and thrombectomy. The
postoperative course was uneventful. In twelve months follow-up the patient shows no signs of reccurrence and
he had no symptoms of cardiac disease. To the best of our knowledge such a case has never been reported
before in the literature.
Background
Coexistence of cardiac and non-cardiac diseases requir-
ing surgical treatment has been a matter of debate for
many years. The major problem concerns patients suf-
fering from cardiac and oncologic diseases. The strategy
of two separate procedures should be taken into consid-
eration when consulting such a case. However, if the
cardiac operation is performed first, the oncologic treat-
ment is delayed and the chances for success are poorer.
Furthermore, the immunosuppressive effect of extracor-
poreal circulation may accelerate tumor growth and dis-
seminate cancer cells [1]. If oncologic operation is
performed first, the risk of operation is very high due to
heart status. There is also an aspect of risk and cost of
two hospital stays and additional anaesthesia.
In this group of patients, cardiac and non-cardiac
operation performed under single anaesthesia seems to
be interesting therapeutic option. However, the com-
bined procedure requires thorough operation plan and
two experienced, harmonious surgical teams. Some sur-
geons have started to perform such procedures. Satisfac-
tory results are reported concerning one-stage cardiac
operation and pulmonary tumor resection [2], carotid
endarterectomy [3], abdominal aortic aneurysm repair
[4], resection of goiter [5] and others.
Till now there has been just few publications on one-
stage cardio-urologic operations [6-9] and there are no
reports concerning patients with combined valvular
heart disease and urologic tumor.
Case presentation
55-year-old man (height 1,78 m; weight 70 kg) with
severe heart failure - NYHA class III/IV was admitted to
cardiology department for evaluation for surgery of
incompetent mitral and tricuspid valves. Transthoracic
echocardiogram confirmed diagnosis of severe mitral
and tricuspid incompetence, dilated left ventricle, poor
contractility (EF - 40%), pulmonary hypertension (PASP
90 mmHg).
On physical examination right lower abdomen mass
was found and CT scan revealed large (12 cm × 11 cm ×
7 cm) right kidney tumor with extension to infradiaph-
ragmatic juxtahepatic part of inferior vena cava (caval
thrombus 9 cm × 5 cm) (See Figures1,2,3).Several options
of treatment were considered but during discussion with
cardiac surgeons and urologists one stage operation was
decided and carefully planed.
In preoperative period patient received hypotensive
drugs (furosemide 0,04 g, spironolactone 0,025 g), beta-
blocker (metoprolol 0,05 g), antyarrhytmic drug
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potassium and magnesium.
Cardiac part of operation was performed first. Chest
was open through median sternotomy and cardiopul-
monary bypass (CPB) was established by cannulation of
both venae cavae and ascending aorta. After clumping
the aorta heart was stopped by cold blood cardioplegia,
and both valves were repaired - dilated mitral annulus
with C-G Future Band (Medtronic Inc.USA) and
tricuspid annulus with De Vega plasty. After aortic
clump was removed heart rhytm was restored with DC
shock. CPB was discontinued without problems, patient
was decannulated, heparin reversed with protamine.
Transoesophageal echocardiogram confirmed good
result of valves repair. The extracorporeal circulation
time was 72 minutes, the aorta was clumped for
49 minutes.
The second part of the operation was carried out just
after the patient was hemodynamically stable. Urologists
performed right radical nephrectomy through laparo-
tomy. Accurate localization of the thrombus was
assessed intraoperatively and a decision not to use cardi-
opulmonary bypass for thrombectomy was made. The
kidney, the adrenal gland and the thrombus were
removed intact (Figure 4).
The operation took 4 hours 25 minutes. Blood loss
was 600 ml. 5 units of fresh frozen plasma (5 × 220 ml),
2 units of red blood cells (2 × 500 ml) and 1 unit of pla-
telets were administered. There were no complications.
Macroscopic evaluation of the specimen showed 10 ×
10 × 9 cm renal mass and 6 × 3 × 4 cm neoplasmatic
thrombus. Microscopic examination revealed clear cell
carcinoma of the kidney at the stage G1 pT3bN0M0,
not infiltrating renal capsule (Figure 5). 10 lymphatic
nodules were negative.
In postoperative echocardiography there were no signs
of mitral either tricuspid incompetence or pericardial
effusion. Electrocardiogram demonstrated regular sinus
rhythm. In peri- and postoperative period patient
received antibiotic prophylaxis (ceftriaxone 2,0 g),
Figure 1 CT scan showing large tumor of the right kidney.
Figure 2 CT scan showing involvement of infradiaphragmatic
juxtahepatic part of inferior vena cava.
Figure 3 CT reconstruction of the abdomen showing the size
of the renal mass and the thrombus.
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beta-blocker (metoprolol 0,05 g), antyarrhytmic (amio-
darone 0,2 g), anticoagulant (enoxaparin 0,06 g), acetyl-
salicylic acid (0,075 g), omeprazole (0,02 g), potassium
and magnesium. 6 days after surgery oral anticoagulant
therapy was started with acenocoumarol (0,002 g).
9 days after the operation the patient was transferred
from cardiosurgical department to urologic centre.
4 days later he was discharged in good condition.
12-month follow-up showed that the patient remains
without any complaints. Computed tomography
demonstrated no signs of reccurrence.
Conclusions
To the best of our knowledge, this is the first reported
case of patient, who underwent one-stage mitral valvulo-
plasty, tricuspid valvuloplasty and radical nephrectomy
with inferior caval vein thrombecotmy. Coexistence of
combined valvular heart disease with severe heart failure
and renal cell carcinoma infiltrating renal and inferior
caval vein rendered this operation as very high risk pro-
cedure. However, the strategy of two separate operations
was contraindicated irrespective of the order of inter-
ventions. Cardiac operation in patient with virtually
total obstruction of inferior caval vein could not make
an expected profit and additionally could be significantly
unfavourable due to the delay of oncological treatment.
On the other hand the risk of urologic operation in
patient with so advanced circulatory insufficiency would
be extremely high.
Till now there has been 4 reports on simultaneous
cardiac procedure and nephrectomy enrolling in total
9 cases [6-9]. Among them there are no reports on such
Figure 4 Polymorphic appearance of renal cell carcinoma of
size 12 × 11 × 7 cm.
Figure 5 Pathological findings of renal cell carcinoma.
Table 1 Data from the literature concerning one-stage cardiac operation and nephrectomy
Author Study
dates
Number of
patients
Cardiac
procedure
Urologic procedure Operative
mortality
Complications Mean
follow-up
time
Follow-up results
Franke
[6]
2000 1 CABG nephrectomy and IVC
thrombectomy
0% No 9 months excellent status, no
signs of recurrence
Litmathe
[7]
1989-
2000
6 4 CABG, 2 aortic
valvuloplasty
5 radical nephrectomy, 1
partial nephrectomy
0% No 72 months 4 alive, 1 ischemic
symptoms
Marino
[8]
2008 1 AVR radical nephrectomy 0% No 0 No
Dedeilias
[9]
2008 1 CABG radical nephrectomy 0% No 17 months excellent status, no
signs of recurrence
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valve nor kidney operations (Table 1).
The aim of this report was to prove the possibility of
simultaneous difficult cardiac and urologic operation.
The most important point of our report concerns the
fact that the oncologic treatment was not delayed
despite severe heart disease. There is also an advantage
in avoiding second operation and hence anesthesia.
Essential disadvantages, which have to be considered are
as follows: increased probability of bleeding due to
heparinization, operation time, its complexity and risk
of patient’s death.
One-stage cardiac and uro-oncologic operation can be
a safe and beneficial procedure, if performed in selected
patients by experienced cardiosurgical and urological
teams. There is a need of greater number of patients
and long term follow-up to establish final conclusions.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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